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Stroke results in damages to many biochemical, molecular and behavioral deﬁcits. Present study provides evidence of the
protective eﬃcacy of a Unani herbal medicine, Majun Khadar (MK), against cerebral ischemia-induced behavioral dysfunctions
and neurochemical alterations in the hippocampus (HIP). Transient focal cerebral ischemia was induced for 2 h followed by
reperfusion for22hinaratmodel.Ratswere divided intofourgroups:sham,middle cerebral artery occluded(MCAO),drug sham
(MK; 0.816gkg−1 orallyfor 15days) and MK pre-treated ischemic group (MK +MCAO).Levels ofenzymatic andnon-enzymatic
antioxidants were estimated in HIP along with behavioral testing. MK pre-treatment signiﬁcantly (P < .05–.001) restored the
activities of glutathione peroxidase (GP×), glutathione reductase (GR), glutathione S-transferase (GST) and decreased the level
of lipid peroxidation (LPO) and H2O2 content in HIP in the MK + MCAO group which were severely altered in the MCAO
group. The content of glutathione (GSH), total thiols (TT) and ascorbic acid (AsA) was signiﬁcantly depleted in the MCAO
group; pretreatment with MK was able to restore its levels. Also in the MK + MCAO group, signiﬁcant (P < .5–.001) recovery
in behavioral testing by rota rod and open-ﬁeld activities was seen as compared with the MCAO group. MK alone did not show
any change neither in the status of various antioxidants nor behavioral functions over sham values. Although detailed studies are
required for the evaluation of exact neuroprotective mechanism of MK against cerebral ischemia these preliminary experimental
ﬁndings conclude that MK exhibits neuroprotective eﬀect in cerebral ischemia by potentiating the antioxidant defense system of
the brain.
1.Introduction
A 100% prophylaxis over cerebral ischemia-induced neu-
ronal death which initiates intracellular acidosis, increased
concentrations of intracellular calcium and overproduction
ofreactiveoxygenspeciesisstillalongwaytocome.Ischemic
damage is severe in those regions where cerebral blood ﬂow
is restored because reﬂow to previous ischemic brain regions
results in an increase in the oxygen level; therefore, severe
oxidative injury occurs [1]. The penumbral region of the
ischemic territory has the potential to be salvaged by timely
drug intervention.
Growing attention is being paid to traditional medicines,
as they have been proved therapeutically/prophylactically
fruitful against manifold diseases, which can be evaluated
by the dependence of 3.2 billion people (64%) of the whole
world population on traditional medicines [2]. Many work-
ers reported the beneﬁcial eﬀects of traditional medicines
against brain ischemia. Yousuf et al. [3, 4], while evaluating
the eﬀect of Khamira Abresham, Majun Baladar against
cerebralischemia-inducedoxidativedamageindiscretebrain
part, report a protective role of these Unani formulations
by the synergistic modulation of its various antioxidant
compounds. Numerous single compounds have also shown
their importance, for example, Saﬀron and herbal extract
of Nardostachys jatamansi were also found to be protective
against cerebral ischemic oxidative damage [5, 6]. Ahmad et
al. [7] reported the neuroprotection oﬀered by sesame oil on
brain hippocampus after focal cerebral ischemic damage.
The promising results of Khamira Abresham and Majun
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against cerebral ischemic damage. MK has 27 constituents,
with diﬀerent therapeutic values and has ﬁrm grounds of
pharmacological eﬃcacy in disorders ranging from heart,
nerve, gastrointestinal disorders, and so forth [8, 9]. These
constituents of MK individually are potent free radical
scavengers(Figure 1)(s aﬀron, borage,mint, cinnamon, Nar-
dostachys jatamansi); anti-inﬂammatory and brain boosting
agents (cinnamon, honey, chebulic, myrobalan, mint); and
vasodilators/nerve relaxants (cardamom, usnea, saﬀron)
(see Table 1 for references). Since the oxidative stress and
inﬂammation play a key role in ischemic neuronal death,
we evaluated the synergistic eﬃcacy of these diﬀerent con-
stituents by testing MK against cerebral ischemia-induced
oxidative damage in rat brain and associated behavioral
dysfunctions.
2.Methods
2.1. Drugs and Chemicals. Glutathione (oxidized and
reduced), nicotinamide adenine dinucleotide phosphate-
reduced form (NADPH), Oubain, Phenol Red, Horseradish
peroxide (Hrp), 1-chloro-2,4-dinitrobenzene (CDNB), 5,5 -
dithiobis-2-nitrobenzoic acid (DTNB) and thiobarbituric
acid (TBA) were purchased from Sigma-Aldrich (St. Louis,
MO, USA).Otherchemicals were ofanalytical reagent grade.
Majun Khadar (MK) was procured from Hamdard (Waqf)
Laboratories (Ghaziabad, Uttar Pradesh, India).
2.2. Animals. Male Wistar rats, weighing 300–350g, were
used for the study. Rats were obtained from the Central
Animal House of Jamia Hamdard, New Delhi, India. They
were housed in polypropylenecagesin air-conditioned room
and allowed free access to pellet diet and water ad libitum.
The studies were carried out in accordance with the oﬃcial
regulations approved by the Animal Ethics Committee of
Jamia Hamdard, New Delhi, India.
2.3. Experimental Protocol. The animals were divided into
four groups (n = 6). The ﬁrst group served as sham and
saline was given orally. The second group was the ischemic
group (MCAO: middle cerebral artery occluded) in which
ischemia was induced for 2 hours followed by reperfusion
for 22 hours. The third group was pre-treated with MK
(0.816gkg−1, orally for 15 days, single dose daily) followed
by ischemia/reperfusion (MCAO + MK group). The fourth
group was pre-treated with MK alone for 15 days as a drug
control. After the last dose of MK was given on day 15,
ischemia/reperfusion was induced on the same day. After
reperfusion, the animals were assessed for neurobehavioral
activities and then sacriﬁced.
2.4. Induction of Ischemia. The right middle cerebral artery
occlusion was produced using an intraluminal ﬁlament
model as earlier described by Longa et al. [11]. In brief,
the rats were anesthetized with chloral hydrate (400mgkg−1,
intraperitoneally). A 4-0 nylon monoﬁlament pre-coated
with poly-l-lysine was inserted into the external carotid
artery and advanced into the internal carotid artery. Two
hours after the induction of ischemia, the ﬁlament was
slowly withdrawn and animals were then returned to their
cages for a period of 22 hours of reperfusion. In the sham-
operated rats, the external carotid artery was surgically
prepared for insertion of the ﬁlament but the ﬁlament
was not inserted. The body temperature of animals was
maintained with an infrared lamp and was continuously
monitored for respiration and unresponsiveness throughout
the surgical procedure. No animal mortality was observed
during experimental procedures.
2.5. Behavioral Study. The behavioral tasks adopted in this
study were designed to assess impairments consistent with
the known functional architecture of the rat brain. The
behavioral tests in each group were performed and the
studieswerecarriedoutbetween9:00a.m.to4:00p.m.under
standard laboratory conditions.All testswere performed and
analyzed by subject blind to the experiment.
2.6. Physical Performance Tests
2.6.1. Rota-Rod (Motor Coordination). Omni rotor (Omni-
tech Electronics Inc., Columbus, OH, USA) was used
to evaluate the motor in-coordination. It consisted of a
rotating rod (75mm diameter), which was divided into four
compartments, permitting test of four rats at a time. The
apparatus automatically recorded time 0.1s, when the rats
fall oﬀ the rotating shaft. The speed was set at 10 rpm and
the cut-oﬀ time was 180s.
2.6.2. Open-Field Tests (LocomotorActivity). Open-ﬁeld tests
were done according to the method of Yamamoto et al. [12]
with slight modiﬁcation at ambient temperature ranging
between 26 and 32◦C. The mean of session totals of vehicle
and treatment groups were compared for locomotion (s),
rest (s), distance travelled (cm), average speed (cms−1).
Videopath analyser (Coulbourn Instrument, Allentown, PA,
USA) consists of an open-ﬁeld chamber (50 × 50 × 35cm),
and a video camera was ﬁxed over the chamber by an
adjacent rod, an activity monitor, a programmer and a
printer. The session total for all parameters was taken.
Observations were recorded for 10 min.
2.7. Tissue Preparation. After producing MCAO and assess-
ment of behavioral parameters, the animals were sacriﬁced
immediately and their brains were taken out to dissect
the hippocampus (HIP). Post-mitochondrial supernatant
(PMS)obtainedfrom10%homogenateoftissuewasusedfor
the estimation of various parameters related with oxidative
stress.
2.8. Biochemical Estimations
2.8.1.Lipid Peroxidation (LPO). TheprocedureofUtleyetal.
[13] was used for the estimation of lipid peroxidation with
some modiﬁcations. One milliliter of homogenate (2.5% in
chilled KCl) was pipetted in a 20ml glass tube and incubated
at 37 ± 1◦C in a metabolic shaker for 60 minutes. Similarly,Evidence-Based Complementary and Alternative Medicine 3
Table 1: Constituents of Majun Khadar (MK).
S.N. Urdu/Arabic
name English name Origin Content
(w/kg) Clinical Importance
(l) Mastagi Mastich Plant/gum 2g Stimulant, catarrh, astringent [10].
(2) Boazyadan Sweet pelitory (Pyrethrum
indicum Linn) Plant/leaves/seed/oil 2g Weakness of nerves, Arthritis, Gout, overall body
strengthener
(3) Shakakal Shekakul (Pustinaca
Secacut L) Plant/Root 2g Sexual debilities
(4) Bheman Behen (Centaurea behen
Linn) Plant/Root 2g Cardiotonic, relaxant, palpitation, delirium, sexual
debilities [10].
(5) Gaozaban Borage (Borage Oﬃcinalis
Linn) Plant/leaves/ﬂowers 2g Cardiotonic, nervine tonic, palpitation, weakness of
brain, pneumonia, T.B, Infectious diseases [10].
(6) Badranjboya Mountain Balm Plant/leaves 2g Strengthens heart, exhilarant, melancholia, nervine
tonic [10].
(7) Sumbul-Teeb Valerian (Valeriana
Oﬃcinalis Linn) Plant/Root 2g Antispasmodic, epilepsy, hysteria, bronchitis, loss of
appetite, liver disorders [10].
(8) Aushna Usnea (Usnea longissima
Linn) (Old man’s beard) Plant/leaves 2g Cardiotonic, palpitation relaxant, delirium [10].
(9) Qust-Shireen Kartas root Plant/Root 2g Respiratory diseases, G.I.T disorders [10].
(10) Elaichi Cardamom Plant/Fruit 2g
Vasodilator,Digestive, Diuretic, Cardiotonic,
Stimulant,carminative, anti-ﬂatulent, cure for
obesity [10].
(11) Barg-
Faranjamshak Ram Tulsi (Sweet Basil) Plant/Seed/leaves 2g Cardiotonic G.I.T disorders [8].
(12) Saad-koﬁ Sipertenius Plant 2g Cardiotonic, nervine tonic, weakness of heart,
weakness of brain, G.I.T disorders, liver diseases [8].
(13) Uood-Saleeb Paeoni Root (Paeonia
oﬃcinalis) Plant/Root 3g Epilepsy, paralysis, facial paralysis,meningities [10]
(14) Dalchini Cinnamon (Cinnamomum
verum) Plant/Bark 3g Gastrointestinal, antibacterial, carminataive,
stimulant,Antiﬂatulant, cardiotonic, gastritis [10].
(I5) Halhiya Kabuli Chebulic Myrobalan
(Terminalis chebula)
Plant/Bark/leaves/
Fruit 4g
Nervine tonic, memory enhancer, stomach &
intestine protectant, eye-sight enhancer, laxative,
blood puriﬁer, cures bleeding, ulceration of gums
[10].
(16)
Takhm
Khaskhas
Safeed
Poppy plant (Papaver
somniferum Linn) Plant/Seed 4g Analgesic, Protects digestive system [10]
(17) Falfol daraz Long pepper (Piper longum
Linn) Plant/Fruit 7g Nerve depressant, Cough, asthama,whooping cough
[10].
(18) Falfal Siyah Black pepper (Piper nigrum
Linn) Plant/Fruit 7g Digestive, expectorant, general body strengthener
[10].
(19) Darong Akrabi Leopard’s bane (Doronicum
hookarii Linn) Plant/Root 7g General body strengthener, cardiotonic, delirium,
paralysis [10].
(20) Sajaz Hindi Cinnamon Tamala Plant/Roots/Wood 7g Cardiotonic, weakness of heart, hypertension,
weakness of brain, antispasmodic [10].
(21) Shahed Honey Animal Antibacterial, antibiotic
(22) Pudina Mint Plant/Leaves 7g Digestive, anti-emetic, Beauty packs [10]
(23) Asaroon Asarum (Asarum
ewrospaeum Linn) Plant/Root/Leaves 7g Nervine tonic, paralysis [10].
(24) Shoranjan Colchicum (Colchicuni
autumale L.) Plant/Bulbs 4g Arthritis [10].
(25) Khoalnajan Galangal (Alpinia galangal
wild) Plant/Roots 2g General body strengthner, Expectorant, Nervine
tonic [10].
(26) Zafran Saﬀron Plant/Flower 1.5g Strengthner, antioxidant [10].4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Hypothetical presentation of possible mechanisms of action of Majun Khadar (MK) against cerebral ischemia. Free radicals and
inﬂammation are two major precipitators of ischemic cell death. Diﬀerent constituents of MK have antioxidant and anti-inﬂammatory
properties and many of them act as vasodilator, relaxant, nervine tonic and nerve stimulant which directly or indirectly prevent ischemic
damage.
1ml of the same homogenate wasp i p e t t e di nac e n t r i f u g e
tube and incubated at 0◦C. After 1 hour of incubation,
1.0ml 5% chilled tetrachloroacetic acid was added followed
by 1.0ml of 0.67% TBA in each vial and proper mixing was
done after each addition. The aliquot from each vial was
transferred to a centrifuge tube and centrifuged at 2000×g
for 15 minutes. Thereafter, the supernatant was transferred
to another tube and placed in the boiling water bath. After
10 minutes, the test tubes were cooled and the absorbance
of each aliquot was measured at 535nm. The rate of lipid
peroxidation was expressed as nanomoles of TBA reactive
substance formed/hours/g of tissue using a molar extinction
coeﬃcient of 1.56 × 105 perM per cm.
2.8.2. Glutathione (GSH). Reduced glutathione was deter-
mined by the method of Jollow et al. [14]. Post-
mitochondrial supernatant was precipitated with sulfosali-
cylic acid (4.0%) in the ratio of 1:1. The samples were kept
at 4◦C for 1 hour and then centrifuged at 1200 × gf o r1 5
minutes at 4◦C. The assay mixture contained supernatant,
0.1MphosphatebuﬀerandDTNB(stock=100mM in0.1M
phosphate buﬀer) in a total volume of 3ml. The optical
density of the reaction product was read at λ 412nm and
results were expressed as nmol GSH/g tissue.
2.8.3. Estimation of Total Thiols (TT). The assay was done
according to the method of Sedlak and Lindsay [15]. The
assay mixture contained 0.2ml of homogenate (10% w/v),
0.1M Tris-EDTA (pH 8.2) and 1.0mM DTNB in total
volumeof2.7mlandmixedwell.Thereafter,8.3mlmethanol
was added and centrifuged at 3500 × gf o r5m i n u t e s .T h e
yellow color developed was read immediately at 412nm in
a spectrophotometer (UV-1601, Shimadzu, Japan). The total
thiol content was calculated by using a molar extinction co-
eﬃcient of 13.6 × 103 M−1 cm−1.
2.8.4. Glutathione Peroxidase (GPx). The activity of GPx was
assayed according to the method described by Mohandas
et al. [16]. The reaction mixture (2ml) consisted of a
1.44ml sodium-phosphate buﬀer (pH 7.4), 0.1ml EDTA
(1mM), 0.1ml of 1mM sodium azide, 50 μl glutathione
reductase (1IUml−1), 0.1ml of 1mM GSH, 0.1ml NADPH
(0.2mM), 0.1ml of 10% PMS and 10μlo f0 . 2 5 m M
H2O2. The enzyme activity was calculated as nmol NADPH
oxidized/minutes/mg protein, using a molar extinction co-
eﬃcient of 6.22 × 103 M−1 cm−1.
2.8.5. Glutathione S-Transferase (GST). The assay for the
activity of GST was measured as described by Habig et al.
[17]. For the assay of GST with CDNB as the substrate,
the reaction mixture (2ml) consisted of a phosphate buﬀer
(0.1M, pH 7.4), 1mM GSH, 10mM CDNB and 10% post-
mitochondrial supernatant. An increase in optical density at
340nm was recorded every 30s for 3 minutes. The results
were calculated by using the molar extinction co-eﬃcient of
9.6 × 103 M−1 cm−1 for CDNB conjugate at 340nm. TheEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: GSH content (a), ascorbic acid (b) and total thiols (c)
in the hippocampus. Values are expressed as means ± SE (n = 6).
Signiﬁcance was determined as ∗P < .001 when compared with
sham; #P < .01 as compared with the MCAO group.
enzyme activity was expressed as nmol of CDNB conjugate
formed/minutes/mg protein.
2.8.6. Glutathione Reductase (GR). The activity was mea-
sured by the method of Carlberg and Mannervick [18].
Brieﬂy, the reaction mixture (2ml) consisted of 1.60ml
of phosphate buﬀer (0.1mM, pH 7.4), 0.1ml NADPH
(0.1mM), 0.1ml EDTA (0.5mM), 0.1ml GSSG (1mM)
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Figure 3: LPO level (a) and H2O2 content in diﬀerent groups in
hippocampus. Values are expressed as means SE (n = 6). Signiﬁcant
diﬀerence ∗P < .001 when compared with sham values; #P < .01
when compared with the MCAO group.
and 0.1ml of post-mitochondrial supernatant (10%). The
reaction mixture was incubated at 30◦Cf o r5m i n u t e s
before adding post-mitochondrial supernatant. The enzyme
activity was determined by measuring the disappearance of
NADPH at 340nm using an extinction co-eﬃcient 6.22 ×
103 M−1 cm−1. Speciﬁc activity of the enzyme was expressed
as NADPH oxidized/minutes/mg protein.
2.8.7. Catalase (CAT). Catalase was estimated by themethod
of Claiborne et al. [19]. The assay mixture consisted of
1.95ml of 0.1M phosphate buﬀer (pH 7.4), 50μlo fp o s t -
mitochondrial supernatant(10%).Thereactionwasinitiated
by adding 1.0ml of 0.019M hydrogen peroxide. A decrease
in optical density at 240nm was recorded after every 30s for
3 minutes. The enzyme activity was calculated in terms of
nmol H2O2 consumed/minutes/mg protein.6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Neurobehavioral activities (locomotion, stereoevents,
distance traveled, rest and rota-rod) in various groups. Signiﬁcance
was determined as xP < .01; yP < .001 when compared with sham
valuesand aP<.05; bP <.01whencomparedwiththeMCAOgroup.
2.8.8. Na+K+ATPase. The activity of Na+K+-ATPase was
determined as inorganic phosphorous (pi) release, using the
method of Svoboda and Mossiger [20]. The Na+K+-ATPase
activity was determined in two reaction media, A and B.
The reaction mixture A consisted of 0.2MKCl, 1.0MNaCl,
0.1MMgCl2,0 . 2 MT r i s - H C lb u ﬀe r ,p H7 . 4 ,a n d0 . 1 m l
of brain homogenate (10%) in a total volume of 2.0ml.
The reaction mixture B consisted of 0.1M MgCl2,1 0 m M
ouabain, 1.0M NaCl, 0.2M Tris-HCl buﬀe r ,p H7 . 4 ,a n d
0.1ml of brain homogenate (10%) in a total volume of
2.0ml. The enzyme reaction was started by adding 0.2ml of
25.0mM ATP at 37◦C and terminated after 15 minutes by
adding1.0ml chilled10%TCA.Themixturewascentrifuged
and the supernatant (0.5ml) was used for the estimation of
inorganic phosphorous according to method of Fiske and
Subborow [21].
2.8.9. Assay for Hydrogen Peroxide (H2O2). Hydrogen per-
oxide was assayed by H2O2-mediated horse-radish peroxide
(Hrp)-dependent oxidation of phenol red by the method
of Pick and Keisari [22] with slight modiﬁcation. 0.2ml
microsomes were suspended in 1.0ml of solution containing
0.28nM phenol red, 8.5 units Hrp, 5.5mM dextrose and
0.05M phosphate buﬀer (pH 7.0) incubated at 37◦Cf o r
60 minutes. The reaction was stopped by the addition of
10ml of NaOH (10N), and then centrifuged at 800g for 5
minutes. The absorbance of the supernatant was measured
at 610nm against reagent blank. The quantity of H2O2
produced, expressed as nmolH2O2/h/g tissue based on the
standard curve of 50–250nMH2O2-oxidized phenol red.
2.8.10. Ascorbic Acid (AsA). The ascorbic acid content was
estimated by the method of Majhi et al. [23]. The reaction
mixture consisted of 0.5ml of 2–4 dinitrophenyl hydrazine
reagent (prepared in 1MHCl) and 0.1ml of supernatant
obtained after precipitationwith 20% TCA.The mixture was
Table 2: Eﬀect of cerebral ischemia on the activity of various
enzymes in the hippocampus.
Enzymes SHAM MCAO MCAO + MK MK ONLY
GP× 16.30 ± 0.93 7.59 ± 0.52a 12.86 ± 1.22x 16.00 ± 1.02
(53.43%) (69.43%) (−1.84%)
GR 34.54 ± 1.50 21.65 ± 1.04a 27.81 ± 1.06x 33.70 ± 1.41
(37.31%) (28.45%) (−2.43%)
GST 16.29 ± 0.72 9.37 ± 0.63a 12.58 ± 0.98y 16.92 ± 0.8l
(42.48%) (34.25%) (15.83%)
CAT 6.38 ± 0.33 3.23 ± 0.21a 4.86 ± 0.38y 5.37 ± 0.41
(49.37%) (50.46%) (−15.83%)
Na+K+ 4.52 ± 0.25 2.21 ± 0.13a 3.46 ± 0.26x 4.21 ± 0.24
ATPase (51.10%) (56.56%) (−6.8%)
Values are expressed as mean ± S.E (n = 6) in nmoles/minutes/mg protein.
Values in parentheses show the percentage increase or decrease with respect
to their control. Signiﬁcance was determined as aP < .001 sham versus
MCAO. xP < .01; yP < .05 MCAO versus MCAO + MK.
incubated at 60◦C for 1 hour. After cooling 2.5ml of 8.5%
H2SO4 wasaddedwhilethetubeswereinice.Theabsorbance
was taken at 540nm and the results were expressed as mg
ASA/g tissue.
2.9. Statistical Analysis of Data. Data were analyzed for
signiﬁcance ofdiﬀerenceusingtheStudent’st-test.Valuesare
expressed as means ± SE (n = 6). The signiﬁcance of results
was ascertained at P < .05.
3.Results
3.1. GSH, AsA and TT. A signiﬁcant decrease (P < .001) in
the status of various endogenous cellular antioxidants, GSH,
AsA and TT homeostasis was observed in the MCAO group
whencomparedwiththeshamgroup(Figures2(a),2(b),and
2(c)). MK pre-treatment exhibited a signiﬁcant restoration
(P < .01) in GSH, AsA and TT content in the MCAO + MK
group when compared with the MCAO group (Figures 2(a),
2(b) and 2(c)). The MK sham group did not alter the status
of GSH, AsA and TT as compared with sham values.
3.2. Antioxidant Enzymes and Na+K+ATPase. Activities of
various antioxidant enzymes and Na+K+ATPase in the
hippocampal region of diﬀerent groups have been listed
in Table 2. The activity of GPx, GR, GST, CAT and
Na+K+ATPase was signiﬁcantly depleted (P < .001) in the
MCAO group when compared with the sham group values.
Whereas in the MCAO + MK group, MK pre-treatment
showed a signiﬁcant (P < .05–.01) restoration in the level of
various enzyme and Na+K+ATPase as comparedwith MCAO
group.MKalonedidnotshowanychangeinthestatusofany
enzyme over control values.
3.3. LPO and H2O2 Content. The level of LPO and H2O2
content adds to the proof of the loss of scavengers and
increased peroxidative damage during cerebral ischemia. A
signiﬁcant increase (P < .001) in the content of LPO andEvidence-Based Complementary and Alternative Medicine 7
H2O2 was observed in the MCAO group when compared
with the sham group. In the MCAO + MK group, a
signiﬁcantdecrease(P <.01)wasseeninthelevelofLPOand
H2O2 when compared with the MCAO group (Figures 3(a)
and 3(b)). The MK sham group did not show any signiﬁcant
alterations in thestatus of TBARS and H2O2 when compared
with the sham group.
3.4. Motor Coordination. Signiﬁcant impairments were
observed at the behavioral outcomes in the ischemic group.
On the rota-rod task, a test that requires good coordina-
tion, balance and sensorimotor function, the MCAO group
showed signiﬁcant (P < .001) impairments in coordination
and balance as compared with the sham animals. Although
they appeared to be motivated to run on the rod, rats with
stroke could not keep up with the accelerationof the rod and
fell approximately twice than controlrat. Butsigniﬁcant (P <
.05) improvement was observed in the MCAO + MK group
in staying on the accelerating rod for a longer duration of
time when compared with the MCAO group (Figure 4).
Open-ﬁeld activity was related to ipsilateral cerebral
hemisphere volume and the motor measurements. Open-
ﬁeld activities (locomotion, stereo events, distances traveled,
average speed and rest) showed signiﬁcant (P < .01) deﬁcits
in the MCAO group when compared with the sham group.
Whereas in the MCAO + MK group, the activities were
reinstated signiﬁcantly (P < .05) when compared with the
MCAO group (Figure 4).
4.Discussion
In this study, supplementation of MK for 15 days signiﬁ-
cantly boosted the neurobehavioral outcomes and neuronal
defense mechanism against cerebral ischemia by increasing
antioxidants activity related to lesion pathogenesis. The
recuperation of the brain from oxidative stress during
reperfusion after ischemia was preceded by recovery of GSH
withitsdependentenzymesanddecreased oxidativedamage.
Restoration of the antioxidant homeostasis in the brain
after reperfusion may have helped the brain recover from
ischemic injury. Although MK is extensively used in Unani
medicine, it lacks scientiﬁc grounds for its eﬃcacy and to
the best of our knowledge this is the ﬁrst study to report
its possible protective mechanisms against cerebral ischemic
damage. One of the universally accepted etiologies of stroke
is imbalance between factors of free radical formation and
the maintenance of the neuronal integrity through the
endogenous defense mechanism. In the present study, the
major cellular defenses (both enzymatic and non enzymatic)
were severely altered in the ischemic group as compared with
the sham group, which was due to the increased formation
of reactive oxygen species (ROS) and dwindling levels of the
radical scavengers. However, this imbalance was prevented
by MK supplementation. A substantial elevation in the LPO
level and H2O2 content along with the depletion in the
activity of various protective antioxidant enzymes in the
ischemic brains which has been validated with immense
earlier reports was observed [3, 4, 24, 25]. However, pre-
treatment with MK resulted in the reversal of the increased
LPO level, H2O2 content and up-regulated the depleted
antioxidant enzymes when compared with the ischemic
group suggesting the decreased formation of ROS or radical
scavenging activity of MK after ischemic injury. Neuronal
and cognitive impairments were seen to be improved after
stroke with decoction of herbs (Gagamjungjihwan) and
(Frustus Euodiae) and the Chinese herbal formula (FBD)
by the restoration of GSH content and lowering the lipid
peroxides during ischemic damage [26, 27].
Diminished supply of oxygen and energy to the brain
leadstowardtheﬁrststepofoxidativedamage.Adrughaving
vasodilatory action may be the answer for this problem
that might increase the oxygen and energy supply. The
neuroprotection oﬀered by MK may be due to the additive
eﬀect of the principle components, for example, saﬀron,
honey, Nardostachys jatamansi, cardamom, mint, cinnamon,
black pepper, mastich and usnea. Saﬀron and its active
component, crocetin has antioxidant potential [28, 29],
lipid lowering and vasodilatory properties which leads to
increased blood ﬂow thereby supplying oxygen and nutrient
to the ischemic penumbra [30]. Honey is a well-known
antioxidant, anti-microbial, wound healing and nutritive
agent with its ﬁnal stamp for accreditation from US Medical
Archives. The presence of various polyphenolic compounds,
pinocembrin, pinobanksin, chrysin, galagin, ascorbic acid,
enzymes(glucoseoxidase,catalaseandperoxidases)attribute
to its antioxidant potential [31, 32]. In the present study,
increased activity of antioxidant enzymes and less peroxida-
tive damage to the brain can be attributed to the presence
of honey in MK. MK also contains Nardostachys jatamansi
which has the potential to scavenge superoxide radicals,
hydroxyl radicals and singlet oxygen [33, 34] due to which it
wasabletooﬀerprotectionduringcerebralischemicdamage.
Malva et al. [35] indicated its neuroprotective property
against signaling pathways involving (Ca2+)i and the redox
state of the cells, which can play its role in ischemic damage.
The mechanism by which Nardostachys jatamansi exerts its
eﬀect is not clearly known but it enhances the function
of gamma amino butyric acid (GABA) [36–38]a n dG A B A
potentiates the treatment of ischemic stroke [39]b e c a u s e
there are increased concentrations of excitatory amino acids.
These properties of Nardostachys jatamansi potentiates the
antioxidant and neuroprotective potential of MK against
cerebral ischemic damage. The presence of mint another
important constituent in MK adds to the anti-inﬂammatory,
antioxidant and/or radical scavenging properties [40–43].
The presence of carveol, an active organic constituent of
mint, and transition elements (e.g., Mn, Zn and Co) is
responsibleforthefreeradicalscavengingactivityofthemint
[44]. All these properties might have synergistically led to
decreased ischemic damage after MK pre-treatment.
Variant behavioral tasks were employed in the present
study to detect motor and sensorimotor dysfunction in rats
after cerebral ischemia. We observed signiﬁcant alterations
in the motor, locomotion, rest time and stereo events in
the ischemic group when compared with the sham group.
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in the mentioned behavioral events was observed when
compared with its respective controls. This amelioration
in behavior may be attributed to the protection oﬀered
by its various pharmacologically important constituents
of MK such as Nardostachys jatamansi, cinnamon, saﬀron
and mint. It might be due to antioxidant potential of
Nardostachys jatamansi that may have helped to restore the
antioxidant levelswhich play an important rolein improving
the behavior. Various reports suggest the improvement in
behavioral outputs oﬀered by Nardostachys jatamansi [45,
46]; our data are in agreement with these previous reports.
The vasodilatory activity of carotenoids present in saﬀron,
antioxidant potential of mint and brain-boosting function
of cinnamon that enhance cognition, working memory,
visual-motor speed added to the eﬀectiveness of MK against
cerebralischemia-induced behavioraldysfunctions [47]. The
collective properties of various constituents of MK such as
increasing blood ﬂow, oxygen content, radical scavenging
and brain boosting actions may have restored the damaged
regions of the brain and thereby improving the behavioral
outcomes.Againa Chinese herbalmedicine, Tokishakuyaku-
san, reported to suppress impairments of lower limbs and
inﬂuencing visuospatial perception for post-stroke patients
[48].
Exploring the intricate protection oﬀered by MK may
bringhealthy, safe, natural, multimodal protectiveproperties
of these various plant extracts which can help to protect
the brain from ischemic damage. In conclusion, MK has
anti-ischemic properties and it protects brain from cerebral
ischemia-induced oxidativedamage duetotheadditiveeﬀect
of its various pharmacologically important constituents
that possess antioxidant, ROS scavenging and vasodilatory
properties. Apart from the above-mentioned eﬃcacies, it
would be very interesting to explore speciﬁcally any possible
neuro-nutrient role of MK in neurological disorders as it has
seven constituents that are nerve boosters.
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